The National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid
On Apr. 12, 2005, the National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid. The…
Moores Cancer Center at UC San Diego opened new consolidated facility
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 15, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
World Cancer Day was established by The World Health Organization
On Feb. 4, 2005, World Cancer Day was established by The World Health Organization. Cancer is a leading…
FDA approved albumin-stabilized nanoparticle formulation of paclitaxel for treatment of breast cancer
In Jan. 2005, the U.S. Food and Drug Administration approved an albumin-stabilized nanoparticle formulation of paclitaxel (Abraxane) for…
The Patient Navigator Research Program assessed impact of patient navigators
In 2005, The Patient Navigator Research Program (PNRP), a National Cancer Institute initiative, was underway to assess the…
The Georgia Legislature passed the Smoke Free Air Act
In 2005, the Georgia Legislature passed the Smoke Free Air Act, banning indoor smoking in publicly accessible buildings,…
The Connecticut Challenge Survivorship Clinic was established at Yale Cancer Cente
In 2005, The Connecticut Challenge Survivorship Clinic was established at Yale Cancer Center providing the first specialized resource…
UW Doctor performed SCCA’s first video-assisted thoracic surgery
In 2005, Dr. Michael Mulligan from the University of Washington performed Seattle Cancer Care Alliance’s (SCCA) first video-assisted…
FDA approved Kepivance for severe oral mucositis in cancer patients undergoing bone marrow transplant
On Dec. 15, 2004, Amgen announced that following priority review, the FDA has approved Kepivance(TM) (palifermin), the first…
The National Cancer Institute study determined that a new molecular test can predict the risk of breast cancer recurrence
On Dec. 10, 2004, a National Cancer Institute supported study determined that a new molecular test byin collaboration…
UI Microbiology Professor Mark Stinski made the discoveries of CMV promoter and was named Iowa Inventor of the Year
On Sept. 30, 2003, University of Iowa (UI) Microbiology Professor Mark Stinski made the discoveries of CMV promoter…
The National Cancer Institute announced the Alliance for Nanotechnology in Cancer
On Sept. 13, 2004, the National Cancer Institute announced the Alliance for Nanotechnology in Cancer, a 5-year initiative…
Karmanos Institute announced $47 million cancer center in Detroit; acquired DMC Cancer Hospital
On Aug. 4, 2004, the Barbara Ann Karmanos Cancer Institute announced plans to build a $47 million clinical…
National Cancer Institute’s Annual Report to the Nation found cancer incidence and death rates on the decline
On Jun. 3, 2004, the National Cancer Institute’s Annual Report to the Nation found cancer incidence and death…
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
The FDA approved oxaliplatin (Eloxatin) for use in the treatment of advanced colorectal cancer
On Jan. 9, 2004, the FDA announced the approval of Eloxatin (oxaliplatin) injection for initial treatment of advanced…
Letrozole was approved by the FDA for the adjuvant treatment of early-stage breast cancer after five years of tamoxifen therapy
In 2004, Letrozole was approved by the FDA for the adjuvant treatment of early-stage breast cancer after five…
Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
Biotechnology | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Therapeutics | Vaccine
The University of Georgia Cancer Center was established
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…
OMRF opened the state’s first small animal magnetic resonance imaging facility
In 2004, the OMRF opened the state’s first small animal magnetic resonance imaging facility. It is one of…
World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
The National Center for Research Resources awarded a $67 million grant to UGA for a Parkinson’s disease study
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Death rates from the lung, breast, prostate, and colorecta cancers continued to decline in the late 1990s
On Sept. 3, 2003, the death rates from the four most common cancersï¾—lung, breast, prostate, and colorectalï¾—continued to…
Results from the Prostate Cancer Prevention Trial showed men taking finasteride had 25 percent fewer diagnoses of prostate cancer than men taking placebo
On Jul. 17, 2003, the results from the Prostate Cancer Prevention Trial (PCPT) were published in New England…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial was announced
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
USC sold the operations of the Kenneth Norris Jr Cancer Hospital to Tenet Healthcare
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
Amgen relocated its cancer research division to Seattle
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…